Effectiveness of biosimilar infliximab CT-P13 compared to originator infliximab in biological-naïve patients with rheumatoid arthritis and axial spondyloarthritis: data from the Portuguese RegisterAuthorsMarona J; Sepriano A; Ramiro S; Almeida D; Brites L; Couto M; Cunha I; Fernandes BM; Garcia J; Melo AT; Nóvoa T; Oliveira M; Pinto P; Santos MJ; Silva C; Fonseca JE; Araújo FC; Read articleThis browser does not support PDFs. Please download the PDF to view it: Download PDF.downloadSection:Original articles
